Skip to main content

Table 3 The surface phenotype of DCs

From: A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma

Patient ID % Expression
  CD14 CD1a HLA-ABC HLA-DR CCR7 CD40 CD80 CD83 CD86
1802 7.8 51.6 98.7 99.7 10.6 99.9 96.4 60.1 96.3
1803 1.4 79.6 99.2 99.9 38.7 99.4 99.1 94.1 99.5
1806 1.5 36.3 99.8 99.8 49.1 99.9 98.5 90.8 99
1808 5.2 53.3 98.8 99.5 43.1 99.4 96.7 75.6 98.7
1812 0.6 83 99.9 99.7 10.3 99.8 99.2 87.4 97.9
1814 0.6 66.5 99.4 99.4 58.3 99.6 98.7 91.5 99.2
1817 1.4 34.7 99.7 98.3 50.3 99.8 96.7 61.8 98
1823 0.8 50.4 99.7 99.6 30.5 99.7 99.3 95.4 99.3